Form 4: Ryan Specialty EVP Mark Katz Receives Stock Options
Statement of Changes in Beneficial Ownership
Ryan Specialty Holdings EVP and General Counsel Mark Katz was granted 33,715 stock options exercisable at $29.66 per share.
Summary
- Mark Stephen Katz, EVP & General Counsel of Ryan Specialty Holdings, Inc., was granted 33,715 stock options.
- The options have an exercise price of $29.66 per share.
- The options are set to expire on May 5, 2036.
- The grant was approved by the compensation and governance committee.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential future dilution of existing shareholders upon the exercise of these options.
Risks
- The value of the options is contingent upon the future performance of the company's Class A common stock.
Future Outlook
The options vest in equal installments on July 1, 2029, 2030, and 2031, indicating a long-term retention strategy for the executive.
Industry Context
StockSavvy.ai notes that equity grants for senior legal and executive leadership are standard practice in the insurance brokerage sector to ensure retention and long-term alignment with corporate governance goals.
Comparison to Industry Standards
- The use of multi-year vesting schedules (2029-2031) is consistent with industry standards for executive compensation packages at publicly traded financial services firms.
- The grant size is typical for an EVP-level role within a company of Ryan Specialty's market capitalization.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | Grant of stock options to EVP & General Counsel approved by the compensation and governance committee. | 05/05/2026 | Standard compensation practice; no material change to governance structure. |
Stakeholder Impact
- Shareholders may experience minor dilution if options are exercised in the future.
Next Steps
- Vesting of options beginning July 1, 2029.
Key Dates
| Date | Description |
|---|---|
| 05/05/2026 | Date of the stock option grant transaction. |
| 05/07/2026 | Date the Form 4 was signed and filed. |
| 07/01/2029 | Initial vesting date for the granted options. |
| 05/05/2036 | Expiration date of the stock options. |
Keywords
Ryan Specialty, Insider Trading, Form 4, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.